News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Michael Hofman: Oliver Sartor presenting PSMAfore at SNMMI
Photo from Michael Hofman/X
Jun 11, 2024, 06:42

Michael Hofman: Oliver Sartor presenting PSMAfore at SNMMI

Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre, shared a post on X/Twitter:

”Oliver Sartor presenting PSMAfore at SNMMI.

All efficacy endpoints favour Lu-PSMA617: better efficacy, quality of life, less side effects. Except, no difference in overall survival.”

Michael Hofman

Source: Michael Hofman/X

cancer Melbourne’s Peter MacCallum Cancer Centre Michael Hofman Oliver Sartor OncoDaily Oncology SNMMI
Special Coverage
Voices
Aug 13, 2025, 14:38
EACR Opens Applications for Rising Star Award 2026
Voices
Aug 13, 2025, 14:34
Kai-Cheng Hsu: PECC 2025 - AI for Health Equity Across Asia-Pacific
Insight
Aug 13, 2025, 14:30
LUMEN-1 Trial Protocol Published in The Journal of Nuclear Medicine - EORTC
Science
Aug 13, 2025, 14:19
Postoperative Stereotactic Radiosurgery for Resected Brain Metastases - ASTRO
Voices
Aug 13, 2025, 14:17
ASCO Podcast Explores Innovative Ways to Reduce Financial Burden of Breast Cancer Care
Science
Aug 13, 2025, 13:57
Diego A Díaz-García: Bridging Clinical Understanding and Biology in Cancer Cachexia
Voices
Aug 13, 2025, 13:46
Stephen Liu: WCLC25 Symposium to Address Treatment of Rare Lung Cancer Subtypes
Societies
Aug 13, 2025, 13:42
Pioneering Trends in Lung Cancer Radiotherapy: RTT Reflections from ESTRO 2025
Insight
Aug 13, 2025, 13:36
Carmen Uscatu: "Give Life" Is Building Romania’s First Pediatric Medical Campus
Insight
Aug 13, 2025, 13:33
Miguel Bronchud: Cognitive Impairment in Chemotherapy and Hormone Therapy in Breast Cancers - A Reality Often Overlooked?
Opinion
Aug 13, 2025, 13:26
E. Shyam P. Reddy: New Oral Drug Targets Tumor Defense to Overcome Chemotherapy Resistance
Insight
Aug 13, 2025, 13:21
Pablo Corral: Optimizing PCSK9 Inhibitor Therapy for Better LDL-C Response